Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,481 | 777 | 95.7% |
| Travel and Lodging | $282.50 | 1 | 2.0% |
| Education | $133.67 | 3 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $108.80 | 5 | 0.8% |
| Honoraria | $78.52 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,688 | 115 | $0 (2024) |
| UCB, Inc. | $1,076 | 40 | $0 (2024) |
| Amgen Inc. | $1,062 | 72 | $0 (2024) |
| EMD Serono, Inc. | $1,059 | 61 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $912.99 | 54 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $830.28 | 59 | $0 (2024) |
| Allergan, Inc. | $665.88 | 38 | $0 (2021) |
| Biogen, Inc. | $629.72 | 50 | $0 (2024) |
| GENZYME CORPORATION | $543.66 | 28 | $0 (2019) |
| PFIZER INC. | $498.38 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,166 | 196 | UCB, Inc. ($813.71) |
| 2023 | $2,313 | 107 | AbbVie Inc. ($517.60) |
| 2022 | $769.37 | 48 | ABBVIE INC. ($241.40) |
| 2021 | $490.99 | 25 | AbbVie Inc. ($205.60) |
| 2020 | $392.84 | 18 | Amgen Inc. ($166.42) |
| 2019 | $771.53 | 52 | Amgen Inc. ($279.15) |
| 2018 | $2,774 | 173 | Teva Pharmaceuticals USA, Inc. ($542.39) |
| 2017 | $2,407 | 168 | Allergan Inc. ($364.15) |
All Payment Transactions
787 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $93.36 | General |
| Category: Critical Care | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Neurology | ||||||
| 12/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Neurology | ||||||
| 11/27/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $36.01 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Neurology | ||||||
| 11/11/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $8.43 | General |
| 11/06/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: Neurology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Neurology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 1,370 | 14,117 | $568,846 | $130,752 |
| 2022 | 39 | 1,843 | 22,010 | $902,346 | $197,547 |
| 2021 | 40 | 1,980 | 30,262 | $1.1M | $230,817 |
| 2020 | 41 | 2,030 | 25,897 | $1.0M | $210,268 |
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 35 | 10,900 | $238,504 | $51,641 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 265 | $51,145 | $18,995 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 73 | 77 | $23,562 | $7,903 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 52 | 52 | $17,160 | $6,675 | 38.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 42 | 87 | $22,806 | $5,725 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $14,111 | $5,544 | 39.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 16 | 19 | $21,384 | $4,922 | 23.0% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 29 | 31 | $24,676 | $4,512 | 18.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 28 | 29 | $12,194 | $2,733 | 22.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 22 | 30 | $13,589 | $2,727 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 36 | $10,476 | $2,500 | 23.9% |
| 70496 | Ct scan of blood vessels of head with contrast | Office | 2023 | 20 | 22 | $27,627 | $2,116 | 7.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 25 | 47 | $14,476 | $1,556 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $3,640 | $1,332 | 36.6% |
| 70498 | Ct scan of blood vessels of neck with contrast | Office | 2023 | 15 | 17 | $18,653 | $1,157 | 6.2% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 14 | 14 | $9,128 | $1,073 | 11.8% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 14 | 60 | $3,000 | $1,054 | 35.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 12 | 20 | $4,374 | $914.39 | 20.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 13 | 14 | $9,285 | $879.39 | 9.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 116 | $789.00 | $741.07 | 93.9% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 17 | 19 | $13,098 | $737.97 | 5.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 43 | 43 | $1,403 | $619.63 | 44.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 39 | 39 | $1,302 | $576.42 | 44.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 32 | $1,205 | $526.72 | 43.7% |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | Office | 2023 | 28 | 441 | $1,323 | $479.36 | 36.2% |
About Dr. Robert Silzer, M.D
Dr. Robert Silzer, M.D is a Neurology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881626257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Silzer, M.D has received a total of $14,084 in payments from pharmaceutical and medical device companies, with $4,166 received in 2024. These payments were reported across 787 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,481).
As a Medicare-enrolled provider, Silzer has provided services to 7,223 Medicare beneficiaries, totaling 92,286 services with total Medicare billing of $769,384. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Little Rock, AR
- Active Since 07/07/2006
- Last Updated 04/17/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1881626257
Products in Payments
- Aimovig (Biological) $836.71
- UBRELVY (Drug) $612.06
- QULIPTA (Drug) $568.67
- KESIMPTA (Drug) $510.39
- Rystiggo (Drug) $508.81
- Rebif (Biological) $476.71
- VYEPTI (Biological) $422.63
- COPAXONE (Drug) $400.92
- BOTOX (Biological) $376.17
- AJOVY (Drug) $323.01
- Albuked (Biological) $311.19
- RYTARY (Drug) $294.69
- TROKENDI XR (Drug) $262.42
- AUBAGIO (Drug) $259.45
- TYSABRI (Biological) $255.47
- NURTEC ODT (Drug) $247.69
- LYRICA (Drug) $234.32
- TECFIDERA (Drug) $213.43
- BOTOX THERAPEUTIC (Biological) $212.50
- BRIUMVI (Drug) $205.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Little Rock
Dr. Shitiz Sriwastava, M.d, M.D
Neurology — Payments: $59,492
John Ironside, M.d, M.D
Neurology — Payments: $46,574
Elizabeth Sullivan, M. D, M. D
Neurology — Payments: $34,316
Bradley Boop, M.d, M.D
Neurology — Payments: $14,081
Dr. Kapil Arya, M.d, M.D
Neurology — Payments: $13,409
Mr. Duane Birky, M.d, M.D
Neurology — Payments: $12,518